Company Filing History:
Years Active: 2022
Title: Ge Ruowen: Innovator in Retinal Angiogenic Disease Treatment
Introduction
Ge Ruowen is a notable inventor based in Singapore, recognized for his contributions to medical science. He has developed innovative solutions aimed at treating retinal angiogenic diseases, showcasing his commitment to advancing healthcare.
Latest Patents
Ge Ruowen holds a patent for Angio-3, a groundbreaking method for treating retinal angiogenic diseases. This patent outlines a method of administering an effective amount of an Angio-3 peptide to subjects suffering from these conditions. His work in this area has the potential to significantly improve patient outcomes.
Career Highlights
Ge Ruowen is associated with Singapore Health Services Pte Ltd, where he applies his expertise in medical research and innovation. His role in this organization allows him to collaborate with other professionals in the field, further enhancing his contributions to healthcare.
Collaborations
Some of his notable coworkers include Michael Belkin and Veluchamy Amutha Barathi. Their collaboration fosters a dynamic environment for research and development, leading to advancements in medical treatments.
Conclusion
Ge Ruowen's work in developing Angio-3 exemplifies the impact of innovation in treating complex medical conditions. His contributions are vital to the ongoing efforts in improving healthcare solutions for retinal diseases.
Inventor’s Patent Attorneys refers to legal professionals with specialized expertise in representing inventors throughout the patent process. These attorneys assist inventors in navigating the complexities of patent law, including filing patent applications, conducting patent searches, and protecting intellectual property rights. They play a crucial role in helping inventors secure patents for their innovative creations.